Status:

RECRUITING

POst-Prostatectomy Ablative Radiation Therapy

Lead Sponsor:

University of Milano Bicocca

Conditions:

Radiation Toxicity

Eligibility:

MALE

18-90 years

Brief Summary

The use of hypofractionated radiotherapy for prostate cancer has matured to a point that in current guidelines extremely hypofractionated image-guided IMRT regimens (6 Gy per fraction or greater) can ...

Detailed Description

In this observational prospective trial eligible patients are those with adverse pathological features or rising PSA after radical prostatectomy proposed for receiving 31 Gy in 5 sessions each of 6.2 ...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA
  • Adenocarcinoma of the prostate treated with radical prostatectomy (any type of radical prostatectomy is permitted including retropubic, perineal, laparoscopic or robotically assisted; there is no time limit for the date of radical prostatectomy).
  • Pathologic T3N0/Nx disease or pathologic T2N0/Nx disease, with or without a positive prostatectomy surgical margin
  • Post-radical prostatectomy PSA of ≥ 0.1 - \< 2.0 ng/mL.
  • Clinical local relapse assessed by Magnetic Resonance Imaging (MRI) of the pelvis
  • ECOG performance status of 0-1
  • No distant metastases at restaging (in case of biochemical failure), within 60 days prior to registration
  • Patients can be on androgen deprivation therapy
  • Ability to understand and willingness to sign a study-specific informed consent prior to study entry
  • EXCLUSION CRITERIA
  • N1 and or M1 patients
  • Prior radiation of any kind to the prostate gland or pelvis
  • Prior brachytherapy is not allowed
  • History of inflammatory colitis or other active severe comorbidities
  • Patients who are on immunosuppressant medication

Exclusion

    Key Trial Info

    Start Date :

    April 15 2021

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 31 2026

    Estimated Enrollment :

    30 Patients enrolled

    Trial Details

    Trial ID

    NCT04831970

    Start Date

    April 15 2021

    End Date

    December 31 2026

    Last Update

    October 25 2022

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    Radiation Oncology, Humanitas Cancer Center (Humanitas University)

    Rozzano, MI, Italy, 20089

    2

    Radiation Oncology, ASST Monza (University of Milan Bicocca)

    Monza, Italy, 20900